Related Articles
KIF18B promotes breast cancer cell proliferation, migration and invasion by targeting TRIP13 and activating the Wnt/β‑catenin signaling pathway
TRIP13 is expressed in colorectal cancer and promotes cancer cell invasion
TRIP13 overexpression promotes gefitinib resistance in non‑small cell lung cancer via regulating autophagy and phosphorylation of the EGFR signaling pathway
Upregulation of TRIP13 promotes the malignant progression of lung cancer via the EMT pathway
Targeting TRIP13 for overcoming anticancer drug resistance (Review)